Abstract
Aurora Kinase Inhibition Overcomes Primary Venetoclax Failure and Leads to Synthetic Lethality in BCL2-Positive Lymphomas Via Upregulation of P53/P21/BAX Axis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have